 Geneva, Switzerland and Boston, MA December 1, 2020 ObsEva SA NASDAQ: OBSV SIX: OBSN, a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive health today announced that Ernest Loumaye, MD, PhD, co-founder and member of the Board of Directors, will give a presentation at the ISGE International Society of Gynecological Endocrinology 19th World Congress Virtual Edition, December 2-5, 2020. 